Global Peptide Therapeutics Market Size By Application, By Route of Administration, By Synthesis Technology, By Geographic Scope And Forecast -Global Trends and Forecasts(2025 to 2034)
Description
Peptide Therapeutics Market Size And Forecast
According To Factview Research, Global Peptide Therapeutics Market was valued at USD 29.33 Billion in 2025 and is projected to reach USD 64.67 Billion by 2027, growing at a CAGR of 9.1% from 2020 to 2027.
Global Peptide Therapeutics Market Outlook
In the report, the market outlook section mainly encompasses fundamental dynamics of the market which include drivers, restraints, opportunities and challenges faced by the industry. Drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.
Factview Research narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements that interests the client. The Global Peptide Therapeutics Market is mainly bifurcated into sub-segments which can provide classified data regarding the latest trends in the market.
Global Peptide Therapeutics Market Competitive Landscape
The Global Peptide Therapeutics Market study report will provide a valuable insight with an emphasis on Global market including some of the major players such as Pfizer Inc., Eli Lilly and Company, Amgen Inc., Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc (GSK), Novartis AG, and Novo Nordisk A/S, Teva Pharmaceuticals Industries Ltd. and Lonza Inc.
According To Factview Research, Global Peptide Therapeutics Market was valued at USD 29.33 Billion in 2025 and is projected to reach USD 64.67 Billion by 2027, growing at a CAGR of 9.1% from 2020 to 2027.
Global Peptide Therapeutics Market Outlook
In the report, the market outlook section mainly encompasses fundamental dynamics of the market which include drivers, restraints, opportunities and challenges faced by the industry. Drivers and restraints are intrinsic factors whereas opportunities and challenges are extrinsic factors of the market.
Factview Research narrows down the available data using primary sources to validate the data and use it in compiling a full-fledged market research study. The report contains a quantitative and qualitative estimation of market elements that interests the client. The Global Peptide Therapeutics Market is mainly bifurcated into sub-segments which can provide classified data regarding the latest trends in the market.
Global Peptide Therapeutics Market Competitive Landscape
The Global Peptide Therapeutics Market study report will provide a valuable insight with an emphasis on Global market including some of the major players such as Pfizer Inc., Eli Lilly and Company, Amgen Inc., Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc (GSK), Novartis AG, and Novo Nordisk A/S, Teva Pharmaceuticals Industries Ltd. and Lonza Inc.
Table of Contents
202 Pages
- 1 Introduction Of Global Peptide Therapeutics Market
- 1.1 Overview Of The Market
- 1.2 Scope Of Report
- 1.3 Assumptions
- 2 Executive Summary
- 3 Research Methodology Of Factview Research
- 3.1 Data Mining
- 3.2 Validation
- 3.3 Primary Interviews
- 3.4 List Of Data Sources
- 4 Global Peptide Therapeutics Market Outlook
- 4.1 Overview
- 4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
- 4.3 Porters Five Force Model
- 4.4 Value Chain Analysis
- 5 Global Peptide Therapeutics Market, By Application
- 5.1 Overview
- 5.2 Cardiovascular Disorder
- 5.3 Respiratory
- 5.4 Cns
- 5.5 Renal
- 5.6 Others
- 6 Global Peptide Therapeutics Market, By Route Of Administration
- 6.1 Overview
- 6.2 Parenteral Route
- 6.3 Oral Route
- 6.4 Pulmonary
- 6.5 Mucosal
- 6.6 Others
- 7 Global Peptide Therapeutics Market, By Synthesis Technology
- 7.1 Overview
- 7.2 Solid Phase Peptide Synthesis (Spps)
- 7.3 Liquid Phase Peptide Synthesis (Lpps)
- 7.4 Hybrid Technology
- 8 Global Peptide Therapeutics Market, By Geography
- 8.1 Overview
- 8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
- 8.2.3 Mexico
- 8.3 Europe
- 8.3.1 Germany
- 8.3.2 U.K.
- 8.3.3 France
- 8.3.4 Rest Of Europe
- 8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Rest Of Asia Pacific
- 8.5 Rest Of The World
- 8.5.1 Latin America
- 8.5.2 Middle East &Amp; Africa
- 9 Global Peptide Therapeutics Market Competitive Landscape
- 9.1 Overview
- 9.2 Company Market Ranking
- 9.3 Key Development Strategies
- 10 Company Profiles
- 10.1 Pfizer Inc.
- 10.1.1 Overview
- 10.1.2 Financial Performance
- 10.1.3 Product Outlook
- 10.1.4 Key Developments
- 10.2 Eli Lilly And Company.
- 10.2.1 Overview
- 10.2.2 Financial Performance
- 10.2.3 Product Outlook
- 10.2.4 Key Developments
- 10.3 Amgen Inc.
- 10.3.1 Overview
- 10.3.2 Financial Performance
- 10.3.3 Product Outlook
- 10.3.4 Key Developments
- 10.4 Takeda Pharmaceutical Company Limited,
- 10.4.1 Overview
- 10.4.2 Financial Performance
- 10.4.3 Product Outlook
- 10.4.4 Key Developments
- 10.5 Glaxosmithkline Plc (Gsk)
- 10.5.1 Overview
- 10.5.2 Financial Performance
- 10.5.3 Product Outlook
- 10.5.4 Key Developments
- 10.6 Novartis Ag
- 10.6.1 Overview
- 10.6.2 Financial Performance
- 10.6.3 Product Outlook
- 10.6.4 Key Developments
- 10.7 Novo Nordisk A/S
- 10.7.1 Overview
- 10.7.2 Financial Performance
- 10.7.3 Product Outlook
- 10.7.4 Key Developments
- 10.8 Teva Pharmaceuticals Industries Ltd.
- 10.8.1 Overview
- 10.8.2 Financial Performance
- 10.8.3 Product Outlook
- 10.8.4 Key Developments
- 10.9 Lonza Inc.
- 10.9.1 Overview
- 10.9.2 Financial Performance
- 10.9.3 Product Outlook
- 10.9.4 Key Developments
- 11 Appendix
- 11.1 Related Research
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


